A federal court in Massachusetts has granted Pfizer and BioNTech’s motion to put on hold Moderna’s lawsuit over alleged ...
Think it's time for a booster? Moderna says its newest COVID vaccine is showing signs of a stronger immune response against the virus than the current shot being offered and a longer shelf-life.
News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...
Moderna Inc. announced Tuesday that its next-generation COVID vaccine produced better immune results in a late-stage trial than its previous vaccines, and will be a key part of its combination ...
Inside a massive, 700,000 square foot warehouse in Sparrows Point a medical glove manufacturer hasn’t produced one glove in ...
Shares of Moderna ... vaccine data is interesting. In his words, says the data suggests the vaccine could potentially work in industries outside of melanoma. He has a buy rating, price target ...
It comes after Pfizer and Moderna, the two key suppliers of Covid vaccines ... with the high price of Boots’ service reflective of the higher cost set by vaccine manufacturers.
CAMBRIDGE, MA / ACCESSWIRE / March 26, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, has successfully met the primary endpoints ...
Vaccine uses patient's own tumor and immune system to fight recurrence of skin cancer. When you think of Moderna mRNA vaccines, you probably think of COVID-19 ... carry a heavy price tag ...
Jefferies' revised price target reflects the potential of these upcoming products and milestones for Moderna, as the company continues to expand its vaccine portfolio and explore new therapeutic ...